Shire plc : Rule 2.9 Announcement
May 30, 2018 02:00 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
May 28, 2018 02:00 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
May 24, 2018 02:00 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Block listing Interim Review
May 23, 2018 10:31 ET
|
Shire Pharmaceuticals Group
BLOCK LISTING SIX MONTHLY RETURN May 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Name of applicant: Shire plc Name of scheme: Shire Sharesave Scheme Period of return: From: ...
Shire plc : Rule 2.9 Announcement
May 23, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Director Declaration
May 22, 2018 11:46 ET
|
Shire Pharmaceuticals Group
Director Declaration May 22, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Olivier Bohuon, Senior Independent Director of the Company, is to be appointed as a...
Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology
May 22, 2018 07:00 ET
|
Shire Pharmaceuticals Group
Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology New Burden of Illness survey data shows patients living with chronic hypoparathyroidism report...
Shire plc : Rule 2.9 Announcement
May 22, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
SHIRE RELEASES DATA AT THE WFH CONGRESS 2018 EVALUATING VONVENDI® IN ADULTS WITH VON WILLEBRAND DISEASE DURING AND AFTER SURGERY
May 22, 2018 02:01 ET
|
Shire Pharmaceuticals Group
P SHIRE RELEASES DATA AT THE WORLD FEDERATION OF HEMOPHILIA CONGRESS 2018 EVALUATING VONVENDI® [VON WILLEBRAND FACTOR (RECOMBINANT)] IN ADULTS WITH VON WILLEBRAND DISEASE DURING AND AFTER...
Shire plc : Rule 2.9 Announcement
May 21, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....